April 2, 2009
Thursday, April 2, 2009 at 11:47AM As per the Tuesday, March 31, Special Update, we sold our entire ARNA positions in both the Model and the Trader’s Portfolios using the same day’s closing price of $3.01. A 1% commission was charged on each transaction.
We also sold DNA from both portfolios with the price DNA shares were tendered to Roche at $95 per share on March 25. A 1% commission was charged on each transaction.
We have dropped coverage of both ARNA and DNA.